期刊文献+

特发性肺纤维化急性加重3例临床分析

Clinical analysis of acute exacerbation of idiopathic pulmonary in three patients
原文传递
导出
摘要 目的提高对特发性肺纤维化急性加重(AEIPF)的临床认识,探讨其临床特点、诊断、治疗与预后。方法分析南京大学医学院附属鼓楼医院2010年9月至2013年11月收治的3例AEIPF患者的临床资料,并复习相关文献。结果 3例均为老年患者,男1例,女2例。均在无明确诱因的情况下1月内病情突然恶化,出现进行性的呼吸困难和严重的低氧血症。胸部高分辨率CT(HRCT)均表现为在原有特发性肺纤维化条索影和网格影、蜂窝肺的基础上出现新的磨玻璃影。接受激素冲击治疗后2例患者呼吸困难症状明显缓解,肺部磨玻璃影较前减少。1例患者胸部HRCT示磨玻璃影改变不明显,尽管使用有创性机械通气,仍死于呼吸衰竭。结论特发性肺纤维化患者可在无诱因下出现急性加重,AEIPF进展快,病死率高。糖皮质激素冲击治疗对部分患者有效。 Objective To improve the awareness of acute exacerbation of idiopathic pulmonary (AEIPF), and to explore its clinical characteristics, diagnosis, treatment and outcome. Methods The clinical data of three patients with AEIPF in the Drum Tower Hospital affiliated to Nanjing University Medical School from September 2010 to November 2013 were recruited.The related literatures were reviewed. Results Three patients were aged from 65-74 years, and one of them was male and two were female. Their condition suddenly deteriorated in one month without clear incentive. Progressive dyspnea and severe hypoxemia were aggravated. Chest high resolution computed tomography (HRCT) showed new groundglass opacities on the basis of reticular shadow, honeycombing, and traction bronchiectasis of idiopathic pulmonary fibrosis. After corticosteroid treatment, the clinical symptoms of dyspnea of two patients significantly relieved, and pulmonary groundglass opacities reduced. However, one patient died of respiratory failure in the case of mechanical ventilation, and the groundglass opacities in his chest HRCT didn't reduce. Conclusions Idiopathic pulmonary fibrosis patients may have acute exacerbation in the absence of incentives.AEIPF progresses quickly and the mortality rate is high.Large dose of glucocorticoid treatment is effective for some part of these patients.
出处 《实用老年医学》 CAS 2014年第4期321-324,共4页 Practical Geriatrics
关键词 特发性肺纤维化 急性加重 磨玻璃影 糖皮质激素 idiopathic pulmonary fibrosis acute exacerbation groundglass opacities corticosteroid
  • 相关文献

参考文献22

  • 1American Thoracic Society;European Respiratory Society. A- merican Thoracic Society/European Respiratory Society in- ternational muhidisciplinary consensos classification of the idiopathic interstitial pneumonias[J] .Am J Respir Crit Care Med, 2002,165 (2) : 277-304.
  • 2Ambrosini V, Cancellieri A, Chilosi M, et al.Acute exacer- bation of idiopathic pulmonary fibrosis: report of a series [ J ].Eur Respir J, 2003,22 (5) : 821-826.
  • 3张德平,侯杰.对特发性肺纤维化急性加重的新认识[J].中华结核和呼吸杂志,2007,30(4):298-300. 被引量:11
  • 4Collard HR, Moore BB, Flaherty KR, et al.Acute exacerba- tions of idiopathic pulmonary fibrosis [ J ]. Am J Respir Crit Care Med, 2007, 176(7) :636-643.
  • 5Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome [ J ].Eur Respir J, 2011,37 (2) : 356-363.
  • 6Kondoh Y, Taniguchi H, Kawabata Y, et al.Acute exacer- bation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases [ J ]. Chest, 1993,103 (6) : 1808-1812.
  • 7Sakamoto K, Taniguchi H, Kondoh Y, et al. Acute exacer- bation of idiopathic pulmonary fibrosis as the initial presenta- tion of the disease [ J ]. Eur Respir Rev, 2009, 18 ( 112 ) : 129-132.
  • 8Hyzy R, Huang S, Myers J, et al.Acute exacerbation of idi- opathic pulmonary fibrosis [ J ]. Chest, 2007, 132 ( 5 ) : 1652-1658.
  • 9Kim DS, Park JH, Park BK, et al.Acute exacerbation of id- iopathic pulmonary fibrosis:frequency and clinical features [J] .Eur Respir J,2006,27( 1): 143-150.
  • 10Yonemaru M, Kasuga 1, Kusumoto H, et al.Elevation of an-tibodies to cytomegalovirus and other herpes viruses in pul- monary fibrosis [ J ]. Eur Respir J, 1997,10 (9) : 2040-2045.

二级参考文献37

  • 1于娜,刘知陶,姜莉,康健.特发性肺纤维化急性加重1例并文献复习[J].中国实用内科杂志,2006,26(7):986-988. 被引量:12
  • 2张德平,侯杰.对特发性肺纤维化急性加重的新认识[J].中华结核和呼吸杂志,2007,30(4):298-300. 被引量:11
  • 3American Thoracic Society, European Respiratory Society.American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (EILS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med, 2002,165:277-304.
  • 4Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J, 2006,27:143-150.
  • 5Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest, 2005,128:3310-3315.
  • 6Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest, 1993,103:1808-1812.
  • 7Tiitto L, Blogu R, Heiskanen U, et al. Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia, Thorax, 2006, 61: 1091-1095.
  • 8Okamoto T, Ichivasu H, Ichikado, et al. Clinical analysis of the acute exacerbation in patients with idiopathic pulmonary fibrosis.Nihon Kokyuki Gakkai Zasshi, 2006,44:359-367.
  • 9Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorae Soc, 2006,3:285-292.
  • 10Ambrosini V, Cancellieri A, Chilosi M, et al, Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J,2003,22:821-826.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部